Manufacturers have long supported efforts to reduce America’s healthcare costs. And with 98 percent of manufacturers offering health benefits to their employees, we are as sensitive as anyone to the rising costs of care.

But we are also mindful that government “solutions” often make the problem worse, as we have witnessed with the many unintended consequences of Obamacare. With the Trump administration seeking ideas on how to reduce the cost of prescription drugs to consumers, we should be careful to avoid any “solution” that would lead to more government intervention into our healthcare.

Recommended Stories

Pharma lobby blasts Trump’s ‘socialized’ drug pricing plan

A high-stakes exam for healthcare leadership

Ted Cruz bill would speed FDA approval of drugs OK’d in other countries